Understanding what autoimmune diseases are, what triggers them and how they’re treated can be a powerful first step toward ...

JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 ...

Asal Shirazi, Founder of ASA Foundation, shares insights into what drives inflammatory responses, including the role of ...

The collaboration with Sanofi focuses on developing bispecific antibodies for autoimmune diseases, leveraging predictive ...

Tissue-resident macrophages are crucial players in the immune system, acting as the first line of defense and maintaining tissue homeostasis by responding to various environmental challenges and ...

Lifordi Immunotherapeutics and other biotechnology companies are using antibodies to precisely target drugs in the body.

Autoimmune neurological diseases are conditions where the immune system attacks nerve cells. Damage to neuronal cells can lead to a variety of neurologic and psychiatric symptoms. Autoimmune diseases ...

Sanofi has returned to U.S. artificial intelligence research biotech Earendil Labs for another significant autoimmune and ...

Although the mechanisms underlying autoimmune disease are becoming clearer, our understanding of why, in some individuals, the immune system can be the cause of life-long, debilitating, and sometimes ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." There are more than 80 autoimmune conditions (lupus, rheumatoid arthritis, celiac disease, and multiple ...

Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, today announced a strategic collaboration with Sanofi to apply Earendil's discovery ...